UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 30, 2006
GENOMIC HEALTH, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-51541
|
|
77-0552594 |
|
|
|
|
|
(State or Other
Jurisdiction of
Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification Number) |
|
|
|
301 Penobscot Drive |
|
|
Redwood City, California
|
|
94063 |
|
|
|
(Address of principal executive offices)
|
|
(Zip Code) |
(650) 556-3900
(Registrants telephone number,
including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF
PRINCIPAL OFFICERS.
On November 30, 2006, the independent members of the Board of Directors of Genomic Health,
Inc. (the Company) approved the following annual base salaries for the Companys named executive
officers, effective December 1, 2006:
|
|
|
|
|
|
|
Name |
|
Title |
|
2007 Salary |
|
Randal W. Scott, Ph.D.
|
|
Chief Executive Officer and Chairman
|
|
$ |
280,000 |
|
Kimberly J. Popovits
|
|
President and Chief Operating Officer
|
|
$ |
340,000 |
|
Joffre B. Baker, Ph.D.
|
|
Chief Scientific Officer
|
|
$ |
310,000 |
|
Steven Shak, M.D.
|
|
Chief Medical Officer
|
|
$ |
315,000 |
|
G. Bradley Cole
|
|
Executive Vice President, Chief
Financial Officer and Secretary
|
|
$ |
286,000 |
|